Home › Funds › Stokes Capital Advisors, LLC › ABBV

Stokes Capital Advisors, LLC position in ABBV

ABBVIE INC · Health Care

Stokes Capital Advisors, LLC reported holding 35,791 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$9.4M, representing 2.06% of its reported portfolio and ranking #15 among its reported holdings. Stokes Capital Advisors, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)35.79K sh
Reported value held$9.36M
Portfolio Weight2.06%
First reportedQ3 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Stokes Capital Advisors, LLC's ABBV position evolved

Stokes Capital Advisors, LLC first disclosed a stake in ABBV in Q3 2023 at 1,390 shares (US$207K). The position peaked in Q2 2026 at 37,456 shares, worth US$9.4M. Across 13 filings, Stokes Capital Advisors, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 35,791 shares valued at US$9.4M — a reduction of -1,665 shares quarter over quarter.. Notable position changes include a 1851% increase in Q4 2023 (shares rose 19% over the following quarter), a 28% increase in Q2 2024 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.39K $207.19K New
Q4 2023 27.12K $4.20M Add
Q1 2024 27.45K $5.00M Add
Q2 2024 35.10K $6.02M Add
Q3 2024 35.11K $6.93M Hold
Q4 2024 36.70K $6.52M Add
Q1 2025 36.77K $7.70M Hold
Q2 2025 38.12K $7.08M Add
Q3 2025 37.78K $8.75M Reduce
Q4 2025 36.52K $8.35M Reduce
Q1 2026 36.84K $8.01M Add
Q2 2026 37.46K $9.43M Add
Q3 2026 35.79K $9.36M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Stokes Capital Advisors, LLC held ABBV?

Stokes Capital Advisors, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Stokes Capital Advisors, LLC's current position in ABBV?

As of Q3 2026, Stokes Capital Advisors, LLC holds 35.79K shares of ABBV (ABBVIE INC), valued at $9.36M, representing 2.06% of its reported portfolio and ranking #15.

Has Stokes Capital Advisors, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Stokes Capital Advisors, LLC reduced its position in ABBV. The position peaked in Q2 2026 at 37.46K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.